Atherectomy Devices Market Size, Share & Trends Analysis Report By Type (Excisional Atherectomy, Laser Ablation Atherectomy, Orbital Atherectomy, Rotational Atherectomy), By Application (Coronary Artery Disease, Peripheral Arterial Disease, Others), By End-User (Hospitals, Ambulatory Surgery Centres, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Atherectomy Devices Market Insights

The global atherectomy devices market size was valued at USD 1.03 billion in 2025 and is projected to grow from USD 1.11 billion in 2026 to USD 2.03 billion by 2034, registering a CAGR of 7.81% during the forecast period from 2026 to 2034. North America dominated the atherectomy devices market with a market share of 39.2% in 2025.

Atherectomy devices are medical tools used to remove or break up plaque that has built up inside blood vessels, particularly in cases of peripheral artery disease (PAD) and coronary artery disease (CAD). These devices are commonly used during atherectomy procedures, which aim to restore blood flow by clearing blocked or narrowed arteries.

The global market is experiencing significant growth, driven by advancements in minimally invasive procedures and technological innovations in vascular intervention. The increasing adoption of rotational, directional, orbital, and laser atherectomy devices is reshaping the industry by offering precise plaque removal, reduced procedural complications, and improved patient outcomes.

Moreover, the integration of robotic-assisted systems, artificial intelligence-driven imaging, and drug-coated balloon (DCB) combination therapies is enhancing procedural efficiency and long-term success rates. The global market is also witnessing a shift toward outpatient and ASCs, driven by cost-effectiveness, shorter hospital stays, and the growing preference for same-day procedures.

Type Insights

Rotational atherectomy systems dominate the global atherectomy devices market due to their superior efficacy in treating heavily calcified arterial lesions. These systems offer precise plaque removal while minimizing vessel trauma, making them highly effective for complex cases of peripheral and coronary artery disease. Their ability to improve lumen patency, optimize stent deployment, and reduce procedural complications has positioned them as the preferred choice among interventional cardiologists and vascular surgeons, driving their widespread adoption in advanced vascular interventions.

Request Customizationto receive a tailored report.

Application Insights

Peripheral arterial disease (PAD) holds the largest market share in the atherectomy devices industry, driven by its high global prevalence and rising incidence. Contributing factors such as diabetes, hypertension, smoking, and obesity have expanded the patient pool, requiring atherectomy procedures. These interventions play a critical role in restoring blood flow, preventing amputations, and improving overall vascular health. As minimally invasive treatments gain traction, the demand for atherectomy devices in PAD management continues to rise, supporting market growth.

End-User Insights

Hospitals remain the leading end-users of atherectomy devices, owing to their well-equipped infrastructure, skilled medical professionals, and high patient influx for vascular procedures. As centers for advanced cardiovascular care, hospitals provide comprehensive treatment options, including complex atherectomy interventions for both peripheral and coronary artery diseases. The availability of cutting-edge imaging technologies, post-procedure monitoring, and emergency care further reinforces hospitals as the preferred setting for atherectomy treatments, ensuring continued market dominance.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America holds the dominant position in the global atherectomy devices market with 41.15% market share, driven by the high prevalence of peripheral artery disease and the strong adoption of advanced vascular interventions. The region benefits from substantial R&D investments, a well-established healthcare infrastructure, and favorable reimbursement policies that encourage the use of atherectomy procedures.

Moreover, the presence of key market players and continuous technological advancements, such as AI-integrated atherectomy systems and robotic-assisted interventions, further accelerate market growth. Rising awareness about minimally invasive procedures and increased screening programs for CVD also contribute to the expanding market.

• U.S. - The U.S. dominates the atherectomy devices industry due to high investments in R&D, an increasing number of clinical trials, and a strong regulatory framework supporting medical advancements. In November 2024, Royal Philips launched the U.S. THOR IDE clinical trial to evaluate its dual-function laser atherectomy and intravascular lithotripsy catheter, simplifying PAD treatment by integrating two therapies into one. This innovation enhances procedural efficiency and improves patient outcomes, driving market growth.
• Canada- Canada’s market for atherectomy devices is growing due to the rising incidence of PAD and coronary artery disease (CAD). Favorable reimbursement policies, strong government support for medical technology, and a well-established healthcare system are key drivers. Moreover, ongoing clinical trials and collaborations between medical institutions and device manufacturers are accelerating innovation. These factors, along with increased awareness of minimally invasive procedures, are contributing to the widespread adoption of atherectomy devices in Canada.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific: Fastest Growing Region with the Highest Market Cagr

Asia-Pacific is projected to experience the fastest growth, driven by increasing cases of PAD, rising healthcare expenditure, and improving access to advanced medical treatments. Rapid urbanization, an aging population, and a growing burden of diabetes and cardiovascular diseases are fueling demand for effective vascular interventions. Government initiatives to enhance healthcare infrastructure, coupled with increasing investments in minimally invasive surgical techniques, are supporting market expansion. Moreover, the growing presence of medical device manufacturers in emerging economies such as China and India is boosting product availability, further driving the adoption of atherectomy devices in the region.

• India – India is experiencing significant growth in the atherectomy devices market, driven by increasing healthcare investments and facility expansions. In December 2024, the Jayadeva Institute of Cardiology and Research Institute inaugurated a new branch in Karnataka, enhancing cardiovascular healthcare accessibility. The rising burden of diabetes and PAD, along with government initiatives to improve cardiac care, is fueling demand for atherectomy procedures, making India a rapidly expanding market for vascular interventions.
• China: China's market for atherectomy devices is expanding due to the rising prevalence of PAD, increasing healthcare expenditure, and rapid advancements in medical technology. Government-led initiatives to enhance healthcare infrastructure and the growing adoption of minimally invasive procedures are pushing growth. Moreover, the presence of domestic and international medical device manufacturers is improving access to innovative atherectomy solutions, making China a key player.
• Japan- Japan is witnessing significant growth in the market, driven by strong R&D investments and increasing clinical trials. In January 2023, Cardiovascular Systems Inc. (CSI) initiated the KAIZEN clinical study to assess its Diamondback 360 peripheral orbital atherectomy system (OAS) for treating calcified plaque in PAD patients. The study aims to support regulatory approval in Japan, highlighting the country’s commitment to advancing vascular interventions and improving patient outcomes.

Europe Atherectomy Devices Market Trends

• Germany- Germany is one of the largest atherectomy device markets in Europe, driven by a high prevalence of peripheral artery disease (PAD) and the widespread adoption of minimally invasive procedures. The country’s well-established regulatory framework and favorable reimbursement policies encourage hospitals and specialized clinics to adopt cutting-edge atherectomy technologies. Moreover, strong collaborations between research institutions and medical device manufacturers contribute to continuous innovation, further propelling market expansion.

Company Market Share

The key players in the global atherectomy devices market are increasingly focusing on adopting various business strategies, such as strategic collaborations, product approvals, acquisitions, and product launches, to gain a competitive edge and expand their market presence. These companies are forming alliances with healthcare providers, academic institutions, and research organizations to accelerate innovation and improve the accessibility of their products.

Ra Medical: An Emerging Player in the Market

RA Medical is a medical technology company specializing in laser-based vascular and dermatological treatments. In the market, the company developed the DABRA excimer laser system, designed for minimally invasive plaque removal in peripheral artery disease (PAD).

Recent developments by RA Medical:

• In March 2022, RA Medical announced the enrolment of 100 subjects in its pivotal clinical study evaluating the DABRA excimer laser system as an atherectomy device for treating peripheral arterial disease (PAD). The study, cleared to enroll up to 125 subjects, aims to assess the system's safety and effectiveness in plaque removal, supporting its regulatory pathway for atherectomy indications.

List of Key and Emerging Players in Atherectomy Devices Market